Ambu's Ascope Gastro and Abox 2 approved by FDA

Two new products can be sent to the US market after Ambu has received the green light from the US health authorities.
Photo: Ambu / PR
Photo: Ambu / PR
by marketwire, translated by daniel pedersen

Ambu has been granted regulatory clearance from the US Food and Drug Administration for its single-use endoscope, Ascope Gastro, and the display unit, Abox 2, the company announces in a press release on Friday.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading